Molecular Partners AG (MOLN)
NASDAQ: MOLN
· Real-Time Price · USD
3.47
-0.05 (-1.42%)
At close: Aug 15, 2025, 2:34 PM
-1.42% (1D)
| Bid | 3.47 |
| Market Cap | 115.82M |
| Revenue (ttm) | 2.23M |
| Net Income (ttm) | -59.49M |
| EPS (ttm) | -2.09 |
| PE Ratio (ttm) | -1.66 |
| Forward PE | -2.09 |
| Analyst | n/a |
| Ask | 3.57 |
| Volume | 2,447 |
| Avg. Volume (20D) | 1,756 |
| Open | 3.59 |
| Previous Close | 3.52 |
| Day's Range | 3.47 - 3.60 |
| 52-Week Range | 3.36 - 7.60 |
| Beta | 0.55 |
About MOLN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MOLN
Website n/a
3 months ago
+2.94%
Molecular Partners shares are trading higher after...
Unlock content with
Pro Subscription
9 months ago
+14.18%
Molecular Partners shares are trading higher after the company announced its radio-DARPin therapy candidate MP0712 was supported by in vivo data presented at the European Association of Nuclear Medicine Congress. The first-in-human start and initial clinical data are expected in 2025.
